Tag: Alnylam
-
Alnylam lung drug fails mid-stage trial
Alnylam lung drug fails mid-stage trial (Reuters) – Alnylam Pharmaceuticals Inc's experimental drug to treat a variety of respiratory infection in lung transplant patients missed the principal objective of a mid-stage trial. The drug, codenamed ALN-RSV01, is being developed to treat respiratory syncytial … Read a lot more on Reuters Relay for Life this weekend…